These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 24333503)

  • 1. The role of FAK in tumor metabolism and therapy.
    Zhang J; Hochwald SN
    Pharmacol Ther; 2014 May; 142(2):154-63. PubMed ID: 24333503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal adhesion kinase as a cancer therapy target.
    Golubovskaya VM
    Anticancer Agents Med Chem; 2010 Dec; 10(10):735-41. PubMed ID: 21214510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment.
    Stokes JB; Adair SJ; Slack-Davis JK; Walters DM; Tilghman RW; Hershey ED; Lowrey B; Thomas KS; Bouton AH; Hwang RF; Stelow EB; Parsons JT; Bauer TW
    Mol Cancer Ther; 2011 Nov; 10(11):2135-45. PubMed ID: 21903606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review.
    Zhou J; Yi Q; Tang L
    J Exp Clin Cancer Res; 2019 Jun; 38(1):250. PubMed ID: 31186061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal adhesion kinase-An emerging viable target in cancer and development of focal adhesion kinase inhibitors.
    Chauhan A; Khan T
    Chem Biol Drug Des; 2021 Mar; 97(3):774-794. PubMed ID: 33191630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting FAK in anticancer combination therapies.
    Dawson JC; Serrels A; Stupack DG; Schlaepfer DD; Frame MC
    Nat Rev Cancer; 2021 May; 21(5):313-324. PubMed ID: 33731845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal adhesion kinase: a potential target in cancer therapy.
    van Nimwegen MJ; van de Water B
    Biochem Pharmacol; 2007 Mar; 73(5):597-609. PubMed ID: 16997283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells.
    Zhang J; He DH; Zajac-Kaye M; Hochwald SN
    Cell Cycle; 2014; 13(19):3143-9. PubMed ID: 25486573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical importance and potential use of small molecule inhibitors of focal adhesion kinase.
    Schultze A; Fiedler W
    Anticancer Agents Med Chem; 2011 Sep; 11(7):593-9. PubMed ID: 21787277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.
    Shanthi E; Krishna MH; Arunesh GM; Venkateswara Reddy K; Sooriya Kumar J; Viswanadhan VN
    Expert Opin Ther Pat; 2014 Oct; 24(10):1077-100. PubMed ID: 25113248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal adhesion kinase signaling - tumor vulnerabilities and clinical opportunities.
    Schlaepfer DD; Ojalill M; Stupack DG
    J Cell Sci; 2024 Jul; 137(14):. PubMed ID: 39034922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting focal adhesion kinase signaling in tumor growth and metastasis.
    Schwock J; Dhani N; Hedley DW
    Expert Opin Ther Targets; 2010 Jan; 14(1):77-94. PubMed ID: 20001212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal adhesion kinase inhibitors are potent anti-angiogenic agents.
    Cabrita MA; Jones LM; Quizi JL; Sabourin LA; McKay BC; Addison CL
    Mol Oncol; 2011 Dec; 5(6):517-26. PubMed ID: 22075057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis.
    Zhao X; Guan JL
    Adv Drug Deliv Rev; 2011 Jul; 63(8):610-5. PubMed ID: 21118706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders.
    Yang M; Xiang H; Luo G
    Biochem Pharmacol; 2024 Jun; 224():116246. PubMed ID: 38685282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy.
    Pang XJ; Liu XJ; Liu Y; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Song J; Jin CY; Zhang SY
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAK signaling in human cancer as a target for therapeutics.
    Lee BY; Timpson P; Horvath LG; Daly RJ
    Pharmacol Ther; 2015 Feb; 146():132-49. PubMed ID: 25316657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAK inhibitors in cancer, a patent review - an update on progress.
    Ye YX; Cao YY; Xu LS; Wang HC; Liu XH; Zhu HL
    Expert Opin Ther Pat; 2024 Aug; 34(8):593-610. PubMed ID: 38946486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
    Wendt MK; Schiemann WP
    Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.
    Stone RL; Baggerly KA; Armaiz-Pena GN; Kang Y; Sanguino AM; Thanapprapasr D; Dalton HJ; Bottsford-Miller J; Zand B; Akbani R; Diao L; Nick AM; DeGeest K; Lopez-Berestein G; Coleman RL; Lutgendorf S; Sood AK
    Cancer Biol Ther; 2014 Jul; 15(7):919-29. PubMed ID: 24755674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.